Suraxavir marboxil is an investigational new drug that is being evaluated by Jiangxi Qingfeng Pharmaceutical for the treatment of influenza virus infection. It is an inhibitor or the cap-dependent RNA-dependent RNA polymerase of the influenza A and B virus.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.